Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Lane

Showing results (141-150 of 257) with videos related to

Pageof 26
Sort By:
American Journal of Surgery|December 5, 2017
Efficacy and safety of transversus abdominis plane blocks versus thoracic epidural anesthesia in patients undergoing major abdominal oncologic resections: A prospective, randomized controlled trialTamer M Shaker, Joseph T Carroll, Mathew H Chung, et al.
The Journal of Urology|September 10, 2018
Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk GroupsSamer Kirmiz, Ji Qi, Stephen K Babitz, et al.
Urologic Oncology|August 3, 2020
Reliability of urinalysis for identification of proteinuria is reduced in the presence of other abnormalities including high specific gravity and hematuriaJessica L Parker, Samer Kirmiz, Sabrina L Noyes, et al.
Journal of Virology|October 22, 2002
Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcomaBrian R Lane, Jianguo Liu, Paul J Bock, et al.
The Journal of Urology|August 8, 2017
A Roadmap for Improving the Management of Favorable Risk Prostate CancerGregory B Auffenberg, Brian R Lane, Susan Linsell, et al.
BJU International|February 16, 2017
Calculating life expectancy to inform prostate cancer screening and treatment decisionsScott R Hawken, Gregory B Auffenberg, David C Miller, et al.
The Journal of Urology|December 23, 2008
Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinomaAnil A Thomas, Brian I Rini, Brian R Lane, et al.
Urology|May 25, 2018
Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate CancerDeborah R Kaye, Ji Qi, Todd M Morgan, et al.
The Journal of Urology|June 15, 2007
A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomyBrian R Lane, Denise Babineau, Michael W Kattan, et al.
The Journal of Urology|October 20, 2022
The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative ExperienceRoshan Paudel, Raghav Madan, Ji Qi, et al.
Pageof 26

Showing results (141-150 of 257) with videos related to

Sort By:
Pageof 26
American Journal of Surgery|December 5, 2017
Efficacy and safety of transversus abdominis plane blocks versus thoracic epidural anesthesia in patients undergoing major abdominal oncologic resections: A prospective, randomized controlled trialTamer M Shaker, Joseph T Carroll, Mathew H Chung, et al.
The Journal of Urology|September 10, 2018
Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk GroupsSamer Kirmiz, Ji Qi, Stephen K Babitz, et al.
Urologic Oncology|August 3, 2020
Reliability of urinalysis for identification of proteinuria is reduced in the presence of other abnormalities including high specific gravity and hematuriaJessica L Parker, Samer Kirmiz, Sabrina L Noyes, et al.
Journal of Virology|October 22, 2002
Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcomaBrian R Lane, Jianguo Liu, Paul J Bock, et al.
The Journal of Urology|August 8, 2017
A Roadmap for Improving the Management of Favorable Risk Prostate CancerGregory B Auffenberg, Brian R Lane, Susan Linsell, et al.
BJU International|February 16, 2017
Calculating life expectancy to inform prostate cancer screening and treatment decisionsScott R Hawken, Gregory B Auffenberg, David C Miller, et al.
The Journal of Urology|December 23, 2008
Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinomaAnil A Thomas, Brian I Rini, Brian R Lane, et al.
Urology|May 25, 2018
Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate CancerDeborah R Kaye, Ji Qi, Todd M Morgan, et al.
The Journal of Urology|June 15, 2007
A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomyBrian R Lane, Denise Babineau, Michael W Kattan, et al.
The Journal of Urology|October 20, 2022
The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative ExperienceRoshan Paudel, Raghav Madan, Ji Qi, et al.
Pageof 26